Correlation Between Blueprint Medicines and Synaptogenix
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Synaptogenix, you can compare the effects of market volatilities on Blueprint Medicines and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Synaptogenix.
Diversification Opportunities for Blueprint Medicines and Synaptogenix
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Blueprint and Synaptogenix is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Synaptogenix go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Synaptogenix
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 1.79 times less return on investment than Synaptogenix. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.93 times less risky than Synaptogenix. It trades about 0.12 of its potential returns per unit of risk. Synaptogenix is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 285.00 in Synaptogenix on September 4, 2024 and sell it today you would earn a total of 28.00 from holding Synaptogenix or generate 9.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Synaptogenix
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Synaptogenix |
Blueprint Medicines and Synaptogenix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Synaptogenix
The main advantage of trading using opposite Blueprint Medicines and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Synaptogenix vs. Annovis Bio | Synaptogenix vs. Cyclo Therapeutics | Synaptogenix vs. Reviva Pharmaceuticals Holdings | Synaptogenix vs. INmune Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |